These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 20811059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma.
    Mäkitie T, Summanen P, Tarkkanen A, Kivelä T.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1414-21. PubMed ID: 11381040
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
    Bronkhorst IH, Vu TH, Jordanova ES, Luyten GP, Burg SH, Jager MJ.
    Invest Ophthalmol Vis Sci; 2012 Aug 09; 53(9):5370-8. PubMed ID: 22743317
    [Abstract] [Full Text] [Related]

  • 6. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163.
    Woodward J, Sisley K, Reeves G, Nichols C, Parsons MA, Mudhar H, Rennie I.
    Int J Exp Pathol; 2004 Feb 09; 85(1):35-43. PubMed ID: 15113392
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma.
    Mäkitie T, Carpén O, Vaheri A, Kivelä T.
    Invest Ophthalmol Vis Sci; 2001 Oct 09; 42(11):2442-9. PubMed ID: 11581181
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J.
    Technol Cancer Res Treat; 2013 Jun 09; 12(3):259-67. PubMed ID: 23289476
    [Abstract] [Full Text] [Related]

  • 16. Inflammatory cell infiltrates in advanced metastatic uveal melanoma.
    Krishna Y, McCarthy C, Kalirai H, Coupland SE.
    Hum Pathol; 2017 Aug 09; 66():159-166. PubMed ID: 28655639
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.
    Paraoan L, Gray D, Hiscott P, Ebrahimi B, Damato B, Grierson I.
    Exp Eye Res; 2006 Oct 09; 83(4):911-9. PubMed ID: 16784742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.